Immuneering Corp — Form D/A
Immuneering Corp of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2020-01-27. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-01-27
- Form: D/A
- Accession: 0001567619-20-001539
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 67
- Date of first sale: 2020-01-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-350433
Issuer
- Name: Immuneering Corp
- CIK: 0001790340
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Phone: 617-500-8080
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Benjamin J Zeskind | Director | Cambridge, MA |
| Benjamin J Zeskind | Executive Officer | Cambridge, MA |
| Laurie B Keating | Director | Cambridge, MA |
| Robert J Carpenter | Director | Cambridge, MA |
| Thomas J Schall | Director | Cambridge, MA |
| Diana F Hausman | Director | Cambridge, MA |
| Peter J Feinberg | Director | Cambridge, MA |
| Andrew J Phillips | Director | Boulder, CO |
| Joseph J Kekst | Director | CAMBRIDGE, MA |
Other filings by this issuer (3)
More